Malawi | Imports and Exports | World | Pharmaceutical products | Value (US$) and Value Growth, YoY (%) | 2012 - 2023
The value of exports of commodity group 30 "Pharmaceutical products" from Malawi totalled $ 22 thousand in 2023. Sales of commodity group 30 from Malawi decreased by 97% in value terms compared to 2022. exports of commodity group 30 "Pharmaceutical products" decreased by $ 838 thousand (cumulative exports of commodity group 30 from Malawi amounted $861 thousand in 2022)
Exports of commodity group 30 "Pharmaceutical products" amounted to 0.002% of total exports from Malawi (cumulative merchandise exports from Malawi totalled $ 965 million in 2023). The share of commodity group 30 in total exports from Malawi decreased by 0.093 p.p. compared to 2022 (it was 0.095% in 2022 and cumulative exports from Malawi were equal to $ 899 million).
Where does Malawi export Pharmaceutical products?
Top export destinations of "Pharmaceutical products" from Malawi in 2023:
- Tanzania with a share of 67% (15.4 thousand US$)
- South Africa with a share of 27% (6.36 thousand US$)
- USA with a share of 1.75% (399 US$)
- Zambia with a share of 1.73% (395 US$)
- India - 73 US$
- Mozambique - 66 US$
- United Kingdom - 21 US$
- Japan - 12.9 US$
- Kenya - 9.88 US$
- Uganda - 9.56 US$
Exports structure of 30 - Pharmaceutical products - from Malawi in 2023 represented by the following main commodity groups:
- 75% (17.1 thousand US$): 3004 - Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale
- 22% (5.13 thousand US$): 3002 - Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc
- 1.53% (349 US$): 3006 - Pharmaceutical goods specified in Note 4 to this Chapter.
- 0.552% (125 US$): 3003 - Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale
- 0.123% (28 US$): 3001 - Glands, organs (extracts, secretions thereof) for organo-therapeutic uses, dried, powdered or not; heparin and its salts; other human or animal substances for therapeutic or prophylactic uses n.e.s.
The value of imports of commodity group 30 "Pharmaceutical products" to Malawi totalled $ 169 million in 2023. Sales of commodity group 30 to Malawi went up by 167% compared to 2022: imports of commodity group 30 "Pharmaceutical products" went up by $ 105 million (the value of imports of commodity group 30 to Malawi was equal to $63 million in 2022)
Imports of commodity group 30 "Pharmaceutical products" accounted for 5.38% of total import flow to Malawi (in 2023, total imports to Malawi amounted to $ 3.14 billion). The share of commodity group 30 in total imports to Malawi increased by 1.4 p.p. compared to 2022 (it was 3.97% in 2022 and cumulative imports to Malawi were equal to $ 1.58 billion).
Where does Malawi import Pharmaceutical products from?
Top trading partners (import of "Pharmaceutical products") of Malawi in 2023:
- India with a share of 39% (66 million US$)
- Belgium with a share of 19.8% (33 million US$)
- Korea with a share of 10.6% (18 million US$)
- Kenya with a share of 6.99% (11.8 million US$)
- China with a share of 5.42% (9.16 million US$)
- Netherlands with a share of 4.34% (7.34 million US$)
- United Kingdom with a share of 2.84% (4.8 million US$)
- Denmark with a share of 1.93% (3.26 million US$)
- United Arab Emirates with a share of 1.07% (1.81 million US$)
- USA with a share of 1.06% (1.8 million US$)
Imports structure of 30 - Pharmaceutical products - to Malawi in 2023 represented by the following main commodity groups:
- 55% (93 million US$): 3004 - Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale
- 36% (62 million US$): 3002 - Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc
- 5.59% (9.46 million US$): 3006 - Pharmaceutical goods specified in Note 4 to this Chapter.
- 1.12% (1.89 million US$): 3005 - Wadding, gauze, bandages and similar articles (for example, dressings, adhesive plasters, poultices), impregnated or coated with pharmaceutical substances or put up in forms or packings for retail sale for medical, surgical, dental or veterinary purposes.
- 1.03% (1.74 million US$): 3003 - Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale
- 0% (78 US$): 3001 - Glands, organs (extracts, secretions thereof) for organo-therapeutic uses, dried, powdered or not; heparin and its salts; other human or animal substances for therapeutic or prophylactic uses n.e.s.
